Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-09-08

FDA Approved: ACCRUFER — Supplemental Application (Shield TX (UK) Ltd)

View source ↗

Summary

The FDA approved a supplemental application for ACCRUFER (ferric maltol) filed by Shield TX (UK) Ltd. This action likely updates labeling or expands indications…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ACCRUFER (FERRIC MALTOL)

Snippet

SUPPL AP for ACCRUFER (FERRIC MALTOL)